NASDAQ:DSGN | Free Cash Flow | Design Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$16.43M$0.00-$16.43M
2025-12-31-$11.97M$34,000.00-$12M
2025-03-31-$16.79M$72,000.00-$16.86M
2024-12-31-$9.86M$0.00-$9.86M
2024-03-31-$12.44M$195,000.00-$12.63M
2023-12-31-$12.8M$27,000.00-$12.83M
2023-03-31-$17.42M$87,000.00-$17.51M
2022-12-31-$15.09M$288,000.00-$15.38M
2022-03-31-$11.83M$76,000.00-$11.9M
2021-12-31-$9.23M$354,000.00-$9.58M
2021-03-31-$3.7M$33,000.00-$3.73M
2020-12-31-$2.84M$14,000.00-$2.86M
2020-03-31-$2.66M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$54.36M$193,000.00-$54.55M
2024-12-31-$43.11M$340,000.00-$43.45M
2023-12-31-$58.56M$256,000.00-$58.82M
2022-12-31-$51.32M$918,000.00-$52.24M
2021-12-31-$29.38M$1.54M-$30.92M
2020-12-31-$8.67M$76,000.00-$8.75M